Improved production of N-acetylglucosamine in Saccharomyces cerevisiae by reducing glycolytic flux

Sang Woo Lee, Min-Kyu Oh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Glucosamine and its derivatives are utilized in the food and biomedical industries. However, current production relies on hydrolysis of natural sources, making it difficult to maintain quality and eliminate allergenic risk. Therefore, microbial production with aid of metabolic engineering is required. We previously demonstrated production of N-acetylglucosamine (GlcNAc) in Saccharomyces cerevisiae by overexpressing an allosteric regulation-free Gfa1p mutant and the haloacid dehalogenase-like phosphatase YqaB. In this study, we further improved GlcNAc production by reducing glycolytic flux. Eukaryotic phosphofructokinase 1 (PFK-1) is allosterically activated by fructose 2,6-bisphosphate (F26BP). Disruption of PFK-2, which synthesizes F26BP, resulted in a slight decrease of GlcNAc production and no significant change of glucose consumption and ethanol production. However, when galactose was used as a sole carbon source to the strain without PFK-2, GlcNAc production was significantly increased and ethanol production was reduced, suggesting that further reduction of glycolytic flux can be used to further improve GlcNAc production. The methodology used in this study can be applied to improve production of carbohydrate derivatives in S. cerevisiae. Biotechnol. Bioeng. Biotechnol. Bioeng. 2016;113: 2524–2528.

Original languageEnglish
Pages (from-to)2524-2528
Number of pages5
JournalBiotechnology and Bioengineering
Volume113
Issue number11
DOIs
Publication statusPublished - 2016 Nov 1

Fingerprint

Acetylglucosamine
Yeast
Saccharomyces cerevisiae
Ethanol
Phosphofructokinase-1
Allosteric Regulation
Fluxes
Metabolic Engineering
Food Industry
Glucosamine
Galactose
Phosphoric Monoester Hydrolases
Hydrolysis
Carbon
Carbohydrates
Glucose
Fructose
fructose 2,6-diphosphate
Metabolic engineering
Derivatives

Keywords

  • metabolic engineering
  • N-acetylglucosamine
  • phosphofructokinase
  • Saccharomyces cerevisiae

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Improved production of N-acetylglucosamine in Saccharomyces cerevisiae by reducing glycolytic flux. / Lee, Sang Woo; Oh, Min-Kyu.

In: Biotechnology and Bioengineering, Vol. 113, No. 11, 01.11.2016, p. 2524-2528.

Research output: Contribution to journalArticle

@article{ba2db04f338944cd9d8d4d132c0e264f,
title = "Improved production of N-acetylglucosamine in Saccharomyces cerevisiae by reducing glycolytic flux",
abstract = "Glucosamine and its derivatives are utilized in the food and biomedical industries. However, current production relies on hydrolysis of natural sources, making it difficult to maintain quality and eliminate allergenic risk. Therefore, microbial production with aid of metabolic engineering is required. We previously demonstrated production of N-acetylglucosamine (GlcNAc) in Saccharomyces cerevisiae by overexpressing an allosteric regulation-free Gfa1p mutant and the haloacid dehalogenase-like phosphatase YqaB. In this study, we further improved GlcNAc production by reducing glycolytic flux. Eukaryotic phosphofructokinase 1 (PFK-1) is allosterically activated by fructose 2,6-bisphosphate (F26BP). Disruption of PFK-2, which synthesizes F26BP, resulted in a slight decrease of GlcNAc production and no significant change of glucose consumption and ethanol production. However, when galactose was used as a sole carbon source to the strain without PFK-2, GlcNAc production was significantly increased and ethanol production was reduced, suggesting that further reduction of glycolytic flux can be used to further improve GlcNAc production. The methodology used in this study can be applied to improve production of carbohydrate derivatives in S. cerevisiae. Biotechnol. Bioeng. Biotechnol. Bioeng. 2016;113: 2524–2528.",
keywords = "metabolic engineering, N-acetylglucosamine, phosphofructokinase, Saccharomyces cerevisiae",
author = "Lee, {Sang Woo} and Min-Kyu Oh",
year = "2016",
month = "11",
day = "1",
doi = "10.1002/bit.26014",
language = "English",
volume = "113",
pages = "2524--2528",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "11",

}

TY - JOUR

T1 - Improved production of N-acetylglucosamine in Saccharomyces cerevisiae by reducing glycolytic flux

AU - Lee, Sang Woo

AU - Oh, Min-Kyu

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Glucosamine and its derivatives are utilized in the food and biomedical industries. However, current production relies on hydrolysis of natural sources, making it difficult to maintain quality and eliminate allergenic risk. Therefore, microbial production with aid of metabolic engineering is required. We previously demonstrated production of N-acetylglucosamine (GlcNAc) in Saccharomyces cerevisiae by overexpressing an allosteric regulation-free Gfa1p mutant and the haloacid dehalogenase-like phosphatase YqaB. In this study, we further improved GlcNAc production by reducing glycolytic flux. Eukaryotic phosphofructokinase 1 (PFK-1) is allosterically activated by fructose 2,6-bisphosphate (F26BP). Disruption of PFK-2, which synthesizes F26BP, resulted in a slight decrease of GlcNAc production and no significant change of glucose consumption and ethanol production. However, when galactose was used as a sole carbon source to the strain without PFK-2, GlcNAc production was significantly increased and ethanol production was reduced, suggesting that further reduction of glycolytic flux can be used to further improve GlcNAc production. The methodology used in this study can be applied to improve production of carbohydrate derivatives in S. cerevisiae. Biotechnol. Bioeng. Biotechnol. Bioeng. 2016;113: 2524–2528.

AB - Glucosamine and its derivatives are utilized in the food and biomedical industries. However, current production relies on hydrolysis of natural sources, making it difficult to maintain quality and eliminate allergenic risk. Therefore, microbial production with aid of metabolic engineering is required. We previously demonstrated production of N-acetylglucosamine (GlcNAc) in Saccharomyces cerevisiae by overexpressing an allosteric regulation-free Gfa1p mutant and the haloacid dehalogenase-like phosphatase YqaB. In this study, we further improved GlcNAc production by reducing glycolytic flux. Eukaryotic phosphofructokinase 1 (PFK-1) is allosterically activated by fructose 2,6-bisphosphate (F26BP). Disruption of PFK-2, which synthesizes F26BP, resulted in a slight decrease of GlcNAc production and no significant change of glucose consumption and ethanol production. However, when galactose was used as a sole carbon source to the strain without PFK-2, GlcNAc production was significantly increased and ethanol production was reduced, suggesting that further reduction of glycolytic flux can be used to further improve GlcNAc production. The methodology used in this study can be applied to improve production of carbohydrate derivatives in S. cerevisiae. Biotechnol. Bioeng. Biotechnol. Bioeng. 2016;113: 2524–2528.

KW - metabolic engineering

KW - N-acetylglucosamine

KW - phosphofructokinase

KW - Saccharomyces cerevisiae

UR - http://www.scopus.com/inward/record.url?scp=84988963332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988963332&partnerID=8YFLogxK

U2 - 10.1002/bit.26014

DO - 10.1002/bit.26014

M3 - Article

C2 - 27217143

AN - SCOPUS:84988963332

VL - 113

SP - 2524

EP - 2528

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 11

ER -